Karen Soares Clover Health Investments, Corp. (CLOV) insider trading activity

Karen Soares is General Counsel & Secretary of CLOVER HEALTH INVESTMENTS, CORP. . Currently has a direct ownership of 1.35 Million shares of CLOV, which is worth approximately $5.95 Million. The most recent transaction as insider was on Feb 14, 2025, when has been sold 5,345 shares (Class A Common Stock) at a price of $4.46 per share, resulting in proceeds of $23,838. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.35M

3.19% 3M change

36.56% 12M change

Total Value Held $5.95 Million

Karen Soares Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 14 2025	SELL Payment of exercise price or tax liability	$23,838 $4.46 p/Share	5,345 Reduced 0.39%	1,352,163 Class A Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$125,347 $4.39 p/Share	28,553 Reduced 2.06%	1,357,508 Class A Common Stock
Jan 07 2025	SELL Payment of exercise price or tax liability	$15,508 $3.6 p/Share	4,308 Reduced 0.31%	1,386,061 Class A Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$19,876 $3.11 p/Share	6,391 Reduced 0.46%	1,390,369 Class A Common Stock
Nov 14 2024	SELL Payment of exercise price or tax liability	$22,927 $3.08 p/Share	7,444 Reduced 0.53%	1,396,760 Class A Common Stock
Oct 31 2024	SELL Payment of exercise price or tax liability	$626,404 $4.12 p/Share	152,040 Reduced 9.77%	1,404,204 Class A Common Stock
Oct 15 2024	BUY Grant, award, or other acquisition	-	450,955 Added 22.47%	1,556,244 Class A Common Stock
Sep 15 2024	SELL Sale (or disposition) back to the issuer	$19,109 $2.99 p/Share	6,391 Reduced 0.57%	1,105,289 Class A Common Stock
Sep 13 2024	SELL Sale (or disposition) back to the issuer	$350,846 $2.99 p/Share	117,340 Reduced 9.55%	1,111,680 Class A Common Stock
Sep 13 2024	BUY Grant, award, or other acquisition	-	259,000 Added 17.41%	1,229,020 Class A Common Stock
Aug 14 2024	SELL Payment of exercise price or tax liability	$13,154 $2.51 p/Share	5,241 Reduced 0.54%	970,020 Class A Common Stock
Jun 15 2024	SELL Payment of exercise price or tax liability	$4,903 $1.09 p/Share	4,499 Reduced 0.46%	975,261 Class A Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$5,345 $1.02 p/Share	5,241 Reduced 0.53%	979,760 Class A Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$4,134 $0.8 p/Share	5,168 Reduced 0.52%	985,001 Class A Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$5,719 $0.95 p/Share	6,020 Reduced 0.6%	990,169 Class A Common Stock
Jan 07 2024	SELL Payment of exercise price or tax liability	$3,668 $0.95 p/Share	3,862 Reduced 0.39%	996,189 Class A Common Stock
Dec 15 2023	SELL Payment of exercise price or tax liability	$4,317 $0.99 p/Share	4,361 Reduced 0.43%	1,000,051 Class A Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$5,129 $1.01 p/Share	5,079 Reduced 0.5%	1,004,412 Class A Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	-	600,000 Added 37.28%	1,009,491 Class A Common Stock

Karen Soares

General Counsel & Secretary

Franklin, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLOV shares.

Notify only if

Value

Insider Trading

Get notified when an Clover Health Investments, Corp. insider buys or sells CLOV shares.

Notify only if

Operation

Value

Type

News

Receive news related to CLOVER HEALTH INVESTMENTS, CORP.

Track Activities on CLOV

Account